Clinical validation of Wave-CAIPI susceptibility-weighted imaging for routine brain MRI at 1.5 T

John Conklin,Maria Gabriela Figueiro Longo,Azadeh Tabari,Augusto Lio Goncalves Filho,Wei Liu,Daniel Nicolas Splitthoff,Wei-Ching Lo,Stephen F. Cauley,Kawin Setsompop,Pamela W. Schaefer,John E. Kirsch,Otto Rapalino,Susie Y. Huang
DOI: https://doi.org/10.1007/s00330-022-08871-8
IF: 7.034
2022-08-06
European Radiology
Abstract:Wave-CAIPI (Controlled Aliasing in Parallel Imaging) enables dramatic reduction in acquisition time of 3D MRI sequences such as 3D susceptibility-weighted imaging (SWI) but has not been clinically evaluated at 1.5 T. We sought to compare highly accelerated Wave-CAIPI SWI (Wave-SWI) with two alternative standard sequences, conventional three-dimensional SWI and two-dimensional T2*-weighted Gradient-Echo (T2*w-GRE), in patients undergoing routine brain MRI at 1.5 T.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?